ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Societies and non-profits at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
79 societies and non-profits are at ESMO 2026 — 100 presentations on the program and 13 with a booth in the exhibit hall. Most represented: Netherlands Comprehensive Cancer Organisation (IKNL) (4 on the program), European Organisation for Research and Treatment of Cancer (EORTC) (4 on the program), Cancer Research UK (4 on the program). As of Nov 2, 2026.
Tumour type
Top represented
Showing 1–8 of 79 organizations
| Organization | ESMO 2026 Attendance |
|---|---|
Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht, Netherlands | |
Independent Dutch cancer knowledge institute in Utrecht that runs the Netherlands Cancer Registry. | Poster Fri Oct 23 13:00–15:00 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Abstract Sun Oct 25 16:35–16:40 |
European Organisation for Research and Treatment of Cancer (EORTC) Brussels, Belgium | |
Independent non-profit that runs international academic cancer clinical trials across Europe. | Booth Exhibiting at Booth S1041 Poster Fri Oct 23 13:00–15:00 Coverage of treatment-related toxicities by EORTC QLQ-C30 and QLQ-H&N43 in head and neck cancer Sarcoma, CNS, head & neck and rare cancersNursing & supportive care Poster Fri Oct 23 13:00–15:00 Diagnosis, treatment and follow-up practices for locally advanced nasopharyngeal cancer (NPC) in non-endemic regions: An EORTC led survey Sarcoma, CNS, head & neck and rare cancers Poster Sat Oct 24 12:00–12:45 Abstract Sat Oct 24 15:47–15:52 |
Cancer Research UK Manchester, United Kingdom | |
A cancer research and support charity based in the United Kingdom. | Poster Fri Oct 23 13:00–15:00 Digital patient reporting of toxicities in phase 1/2a cancer clinical trials Nursing & supportive care Poster Fri Oct 23 15:15–16:00 TARGET: A precision medicine programme for matching experimental therapy using circulating tumour DNA Biomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Tie2 is the first vascular response biomarker for VEGFi Gastrointestinal cancersGynaecological cancersBiomarkers & precision oncology Abstract Sun Oct 25 09:19–09:24 |
World Health Organization Geneva, Switzerland | |
United Nations agency for international public health, based in Geneva, Switzerland. | Talk Fri Oct 23 16:35–16:55 Talk Sat Oct 24 10:35–10:55 Talk Sat Oct 24 10:55–11:15 Chair Sat Oct 24 14:45–16:15 Abstract Sat Oct 24 15:52–16:07 Chair Sun Oct 25 08:30–10:00 Talk Sun Oct 25 08:30–08:35 |
LA Latin American Cooperative Oncology Group Porto Alegre, Brazil | |
Nonprofit academic cooperative group that designs and runs cancer clinical trials across Latin America, based in Porto Alegre, Brazil. | Abstract Fri Oct 23 16:25–16:30 Poster Sat Oct 24 12:00–12:45 Talk Sat Oct 24 16:30–16:45 How can we incorporate combination strategies in early drug development? Breast cancerBiomarkers & precision oncology Chair Sat Oct 24 16:30–18:00 Novel concepts for metastatic breast cancer: Looking to the future Breast cancerBiomarkers & precision oncology Satellite Sat Oct 24 18:55–19:05 Interactive panel discussion Breast cancer Satellite Sat Oct 24 19:05–19:20 Satellite Sat Oct 24 19:20–19:30 Interactive panel discussion Breast cancer Satellite Sat Oct 24 19:40–19:50 Interactive panel discussion Breast cancer Talk Sun Oct 25 10:15–10:45 Metastatic breast cancer: Case presentation & Discussion Breast cancerGenitourinary cancers Satellite Sun Oct 25 18:30–20:00 Gilead and Kite Oncology - The ADC Evolution in Breast and Gynaecologic Cancers: Foundation, Advancement, Future Directions Breast cancerGynaecological cancers Satellite Sun Oct 25 18:30–18:35 Welcome and Introduction Breast cancerGynaecological cancers Satellite Sun Oct 25 18:35–19:00 Clinical Foundation: Building and Broadening the Role of ADCs in Metastatic Breast Cancer Breast cancerGynaecological cancers Satellite Sun Oct 25 19:45–20:00 Connecting Experience, Potential, and Future Frontiers: Panel discussion and audience Q&A Breast cancerGynaecological cancers |
Cancer research agency of the World Health Organization in Lyon, France, studying the causes of cancer and how to prevent it. | Chair Sat Oct 24 10:15–11:45 Talk Sat Oct 24 10:15–10:35 Talk Sat Oct 24 11:15–11:35 Talk Sun Oct 25 09:20–09:35 |
Cancer Patients Europe Brussels, Belgium | |
Patient advocacy organisation in Brussels representing cancer patients, survivors and carers in European health policy. | Satellite Sat Oct 24 12:40–12:50 Current experience of patients receiving SC IO Nursing & supportive care Talk Sun Oct 25 09:45–09:55 CN35 - Nutrition in cancer care: Closing the gap between awareness and action Nursing & supportive care Abstract Sun Oct 25 11:03–11:13 |
Digestive Cancers Europe (DiCE) Brussels, Belgium | |
European umbrella organisation of patient groups for colorectal and other digestive cancers, based in Brussels, Belgium. | Chair Sun Oct 25 16:30–18:00 Talk Sun Oct 25 17:15–17:30 Talk Mon Oct 26 15:25–15:45 |
Find buyers from societies and non-profits
Tell us what you sell and we’ll find the people at these societies and non-profits most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ESMO 2026 by
Organization type
Tumour type
Exhibit hall
Everyone
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction